India develops National Action Plan to combat Antimicrobial Resistance
Antimicrobial resistance is a serious threat to global public health that requires action across all government sectors: J P Nadda
Healthcare needs to be affordable, accessible and adhere to quality standards: J P Nadda
Cabinet approves National Health Policy 2017
A huge milestone in the history of public health in India: J P Nadda
It provides policy framework for achieving universal health coverage, and is patient-centric and quality-driven: J P Nadda
Shri J P Nadda addresses WHO Regional Health Ministers Meeting on TB; highlights the achievements of India in containing TB
We are committed to the high-impact actions required for eliminating TB by 2025: J P Nadda
Government to establish 4,000 dialysis centres across the country, says J P Nadda
Rise in health awareness to take nutraceuticals market to $ 8.5 bn by 2022
Strand Life Sciences' liquid biopsy test to help early detection of cancer
Unichem receives US FDA nod for pain killer piroxicam capsule
Regenerative Medical Services receives DCGI nod for cell therapy product
Glenmark receives US FDA nod for cholesterol-lowering drug fenofibrate